Tumor Necrosis Factor Receptors Types 1 and 2 Differentially Regulate Osteoclastogenesis
Open Access
- 1 September 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (35) , 27307-27310
- https://doi.org/10.1016/s0021-9258(19)61511-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Interferon-γ rescues TNF-α-induced apoptosis mediated by up-regulation of TNFR2 on EoL-1 cellsExperimental Hematology, 1999
- Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1.Journal of Clinical Investigation, 1998
- A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signalingEuropean Journal of Immunology, 1997
- Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.Journal of Clinical Investigation, 1997
- The Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized MiceJournal of Bone and Mineral Research, 1997
- Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency.Journal of Clinical Investigation, 1997
- Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell DeathCell, 1996
- Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenesNature, 1993
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNFCell, 1988